Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-27

Clinical Trial Update: Ephedrine and Phenylephrine for Spinal Hypotension [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports completed Phase 2 and Phase 3 studies evaluating ephedrine and phenylephrine for spinal hypotension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ephedrine (ephedrine)
  • Phenylephrine (phenylephrine)

Snippet

Sponsor: Assiut University | Conditions: Spinal Hypotension | Phase 2, Phase 3 | Status: COMPLETED